Knoll Capital Management as of June 30, 2018
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 19 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abeona Therapeutics | 32.1 | $38M | 2.4M | 16.00 | |
| Biohaven Pharmaceutical Holding | 25.2 | $30M | 750k | 39.52 | |
| Corbus Pharmaceuticals Hldgs | 16.8 | $20M | 3.9M | 5.05 | |
| Electrocore | 5.6 | $6.6M | 397k | 16.51 | |
| Ampio Pharmaceuticals | 4.8 | $5.7M | 2.6M | 2.20 | |
| Krystal Biotech (KRYS) | 3.8 | $4.5M | 300k | 14.87 | |
| Entera Bio (ENTX) | 2.5 | $3.0M | 476k | 6.30 | |
| Galmed Pharmaceuticals | 2.1 | $2.5M | 210k | 11.90 | |
| Vascular Biogenics | 1.7 | $2.0M | 897k | 2.20 | |
| Anavex Life Sciences (AVXL) | 1.6 | $1.9M | 724k | 2.62 | |
| Aldeyra Therapeutics (ALDX) | 0.8 | $987k | 124k | 7.95 | |
| Eiger Biopharmaceuticals | 0.8 | $918k | 75k | 12.20 | |
| Soligenix | 0.7 | $813k | 838k | 0.97 | |
| Volitionrx (VNRX) | 0.6 | $703k | 352k | 2.00 | |
| Evoke Pharma | 0.6 | $688k | 275k | 2.50 | |
| Chromadex Corp (CDXC) | 0.1 | $178k | 48k | 3.72 | |
| Lipocine | 0.1 | $65k | 50k | 1.30 | |
| Catasys | 0.1 | $61k | 9.1k | 6.72 | |
| Advaxis | 0.0 | $20k | 113k | 0.18 |
